Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Welte

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
BMC Nephrology|September 3, 2023
Correction to: Clinical covariates influencing clinical outcomes in primary membranous nephropathyLukas Westermann, Felix A Rottmann, Martin J Hug, et al.
Scientific Reports|October 31, 2025
Long read sequencing reveals novel genomic and epigenomic alterations in repetitive regions of high grade serous ovarian cancerShiro Takamatsu, Jian Li, Thomas Welte, et al.
BMC Nephrology|January 11, 2023
Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective studyThomas Welte, Frederic Arnold, Lukas Westermann, et al.
FEMS Immunology and Medical Microbiology|March 27, 2010
gammadelta T cells promote the maturation of dendritic cells during West Nile virus infectionHao Fang, Thomas Welte, Xin Zheng, et al.
Virus Research|May 15, 2012
A hamster-derived West Nile virus strain is highly attenuated and induces a differential proinflammatory cytokine response in two murine cell linesVandana Saxena, Thomas Welte, Xiaoyong Bao, et al.
BMC Nephrology|January 14, 2018
Treating C3 glomerulopathy with eculizumabThomas Welte, Frederic Arnold, Julia Kappes, et al.
BMC Nephrology|August 10, 2023
Clinical covariates influencing clinical outcomes in primary membranous nephropathyLukas Westermann, Felix A Rottmann, Martin J Hug, et al.
Vaccine|May 10, 2011
Immune responses to an attenuated West Nile virus NS4B-P38G mutant strainThomas Welte, Guorui Xie, Jason A Wicker, et al.
Molecular Biology of the Cell|December 14, 2011
Promiscuous targeting of polytopic membrane proteins to SecYEG or YidC by the Escherichia coli signal recognition particleThomas Welte, Renuka Kudva, Patrick Kuhn, et al.
Transplantation Direct|August 9, 2016
Successful Management of Calciphylaxis in a Kidney Transplant Patient: Case ReportThomas Welte, Frederic Arnold, Kristin Technau-Hafsi, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
BMC Nephrology|September 3, 2023
Correction to: Clinical covariates influencing clinical outcomes in primary membranous nephropathyLukas Westermann, Felix A Rottmann, Martin J Hug, et al.
Scientific Reports|October 31, 2025
Long read sequencing reveals novel genomic and epigenomic alterations in repetitive regions of high grade serous ovarian cancerShiro Takamatsu, Jian Li, Thomas Welte, et al.
BMC Nephrology|January 11, 2023
Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective studyThomas Welte, Frederic Arnold, Lukas Westermann, et al.
FEMS Immunology and Medical Microbiology|March 27, 2010
gammadelta T cells promote the maturation of dendritic cells during West Nile virus infectionHao Fang, Thomas Welte, Xin Zheng, et al.
Virus Research|May 15, 2012
A hamster-derived West Nile virus strain is highly attenuated and induces a differential proinflammatory cytokine response in two murine cell linesVandana Saxena, Thomas Welte, Xiaoyong Bao, et al.
BMC Nephrology|January 14, 2018
Treating C3 glomerulopathy with eculizumabThomas Welte, Frederic Arnold, Julia Kappes, et al.
BMC Nephrology|August 10, 2023
Clinical covariates influencing clinical outcomes in primary membranous nephropathyLukas Westermann, Felix A Rottmann, Martin J Hug, et al.
Vaccine|May 10, 2011
Immune responses to an attenuated West Nile virus NS4B-P38G mutant strainThomas Welte, Guorui Xie, Jason A Wicker, et al.
Molecular Biology of the Cell|December 14, 2011
Promiscuous targeting of polytopic membrane proteins to SecYEG or YidC by the Escherichia coli signal recognition particleThomas Welte, Renuka Kudva, Patrick Kuhn, et al.
Transplantation Direct|August 9, 2016
Successful Management of Calciphylaxis in a Kidney Transplant Patient: Case ReportThomas Welte, Frederic Arnold, Kristin Technau-Hafsi, et al.
Pageof 8